Movano Health prices $8.0M public offering of 8M shares at $1.00 per share

Corvex, Inc.

Gross proceeds of $8.0M from offering of 8,000,000 shares at $1.00/share.
Underwriter granted 30-day option to purchase up to additional 1.2M shares (15%).
Offering expected to close June 15, 2023; net proceeds for product development and commercialization.
Benchmark Company, LLC acting as sole book-running manager.
Shares offered under previously effective S-3 shelf registration statement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Corvex, Inc. entered into Underwriting Agreement with The Benchmark Company, LLC valued at $8.0 million (effective 2023-06-13).

Action: entry
Agreement: underwriting
Counterparty: The Benchmark Company, LLC
Value: $8.0 million
Effective: 2023-06-13

Exact text from the filing

On June 13, 2023, Movano Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with The Benchmark Company, LLC (the “Underwriter”) relating to an underwritten offering (the “Offering”) of 8,000,000 shares (“Shares”) of common stock (“Common Stock”).

View on SEC.gov

Browse all material agreements →

Corvex, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-048353

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.